Posted in Direct-Pay Practice Models, Economic Issues, Medical Costs, Medicare, Patient Choice, Patient-centered Care, Pre-existing Conditions, Price Tansparency, Quality, Tax Policy, Technology, Uncategorized

Making Sense of Health Care Prices | John Goodman’s Health Policy Blog | NCPA.org

Making Sense of Health Care Prices | John Goodman’s Health Policy Blog | NCPA.org.

Posted in Deductibles, Economic Issues, Employee Benefits, Health Savings Accounts (HSA's), Medical Costs, Medicare, Patient Choice, Pre-existing Conditions, Price Tansparency, Quality, Tax Policy, Technology, Uncategorized

Health Care Reform: Do Other Countries Have the Answers?

Very Eye Opening!  This is one of the most comprehensive, balanced and scholarly articles that I have read on how the U.S. really stacks up against other countries.  The conclusions may surprise you!  It is worth a few minutes of your time.    http://www.ncpa.org/pdfs/062409ECHearingNCPAGoodman.pdf

Posted in Affordable Care Act (ObamaCare), Deductibles, Doctor-Patient Relations, Economic Issues, Independent Physicians, Medical Costs, Medicare, News From Washington, DC & Related Shenanigans, Patient Choice, Patient-centered Care, Pre-existing Conditions, Technology, Uncategorized

Are We About To Face A Severe Doctor Shortage? | John Goodman’s Health Policy Blog | NCPA.org

Are We About To Face A Severe Doctor Shortage? | John Goodman’s Health Policy Blog | NCPA.org.

Posted in Doctor-Patient Relations, Economic Issues, Medical Costs, Medicare, Patient Choice, Price Tansparency, Quality, Reforming Medicare, Technology, Uncategorized

An effective eye drug is available for $50. But many doctors choose a $2,000 alternative. – The Washington Post

An effective eye drug is available for $50. But many doctors choose a $2,000 alternative. – The Washington Post.